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Abstract
This paper summarizes prevalence of Toxoplasma gondii in humans and animals and associated correlates of
infection, clinical spectrum of disease in humans, and genetic diversity of T. gondii isolates from Colombia. Recent
studies, especially in the states of Antioquia, Quindío and Cundinamarca, indicate that toxoplasmosis is a major
public health problem. Approximately half of the women of child bearing age have T. gondii antibodies, and the
clinical disease in congenitally infected children is more severe than in Europe. Limited studies indicate that the
strains of T. gondii from Colombia are genetically and phenotypically different than in Europe and North America.
However, epidemiological factors, such as the involvement of domestic and/or wild animals in transmission, the
distribution of strain diversity by natural geographic regions, and the variation in risk factors between regions that
are associated with human infection in Colombia, remain unknown. Areas of research for the future are outlined.
This review should be of interest to biologists, veterinarians, physicians, and parasitologists.
Keywords: Colombia, Epidemiology, Toxoplasma gondii, Toxoplasmosis, Congenital, Ocular, Genotypes, Public
health, Outbreaks
Review
Toxoplasmosis is a worldwide zoonosis with asymptom-
atic infections in most adult immunocompetent humans.
Why some persons infected with Toxoplasma gondii
become sick and even die is not completely understood.
Recently, in French Guiana, immunocompetent adults
died of toxoplasmosis [1]. In Brazil, a higher proportion
of congenitally infected children developed severe dis-
ease and the onset of clinical symptoms was also earlier
than such cases from the rest of the world [2].
Host and/or parasite factors play a pathogenic role. In
addition, it has been hypothesized that the strains of
T. gondii involved might influence the severity of
toxoplasmosis [3]. Recent studies indicate that the
strains of T. gondii from South America are phenotyp-
ically and genetically different from those in Europe
and North America [4,5]. Information obtained from
studies in Brazil and some recent studies in Colombia
indicate that a similar scenario might apply to both
countries with severe clinical consequences in con-
genitally infected children.
Although Colombia has the third greatest human
population of South America (47 million habitants) and
harbors one of the highest biodiversities in the world [6],
there is no systematic review of the literature for studies
on toxoplasmosis. Here, we review toxoplasmosis in
humans and animals from Colombia and highlight the
need for further studies on toxoplasmosis as a real pub-
lic health problem.
History and introduction
Historically, T. gondii was first found in a Colombia in
a naturally infected guinea pig (Cavia porcellus) [7] but
little else was known until Roca-García et al. [8] pub-
lished the first detailed description of a case of congenital
toxoplasmosis in a 40 day-old girl born to an apparently
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healthy mother from Bogota, Colombia. The child had
classical Sabin’s tetrad symptoms of congenital toxoplas-
mosis including bilateral chorioretinitis, hydrocephalus,
cerebral calcifications, jaundice, hepatomegaly and spleno-
megaly. T. gondii was isolated from the cerebrospinal fluid
by bioassay in mice and the strain was found to be virulent
for mice, guinea pigs, rabbits, chickens and pigeons. These
authors provided an update of toxoplasmosis in children
worldwide at that time [8].
The need for prenatal screening of women was recog-
nized in 1970’s, and Restrepo et al. [9] made an initial
attempt to screen 120 women. They found that half of
the women were seronegative and 8.3% became seroposi-
tive during pregnancy; viable T. gondii was isolated from
10 of 30 placentas obtained from these women [9]. These
observations eventually led to the first national serological
study in the general population, in 1980, and then to a
multicenter study of congenital toxoplasmosis [10].
Varela and Roca [11] performed the first serological
survey in Indian Guambias in Cauca, Colombia by using
the Sabin Feldman dye test (SF). Feldman [12], coauthor
of the SF test, reported that T. gondii seroprevalence in
Colombia was approximately four times that in the USA.
He tested sera from military recruits and found that
seroprevalence was 50% of 2,803 from Colombia, 56% of
2,023 from Brazil, and 14% 2,680 from the USA using
the SF test. These findings are of historic importance
because we are not aware of any other study where
prevalence has been compared in humans (all males) of
one age group from three countries by one laboratory
using identical methodology.
The SF dye test is the most specific test for the detec-
tion of antibodies to T. gondii in humans and even low
titers (1:4–1:16) are considered specific [13]. However,
this test is technically difficult, hazardous to perform
(because live virulent T. gondii are needed for the test),
and not used now in Colombia or in most other countries.
Since then, several other serological tests have been devel-
oped, and data based from other tests are not always com-
parable. We have summarized in Table 1 all serological
tests used for studies in Colombia, so that readers can
draw their own conclusions concerning the prevalence of
T. gondii antibodies in humans and animals summarized
throughout the review. Cut-off values are indicated in Ta-
bles wherever the authors provided the information.
Review methodology
Using the key terms “Toxoplasma [and] Colombia” and
“Toxoplasmosis [and] Colombia” to search publications
from 1944 to 2014, we queried PubMed, Medline, SciELO
and Google Scholar. National and international scientific
journals were systematically reviewed and originals of all
papers were consulted. After excluding summaries of con-
ference reports, 90 publications met our selection criteria,
including original articles (64), clinical trials (5), case
reports (19) and reviews (2).
Toxoplasmosis in humans
Seroprevalence and correlates of infection
Data are summarized in Tables 2, 3 and 4 and Figure 1.
There are several reports of T. gondii seroprevalence
in the general human population, most of them based
on convenience samples. A national study, using the in-
direct fluorescent antibody test (IFAT, cut-off 1:16),
found an overall prevalence of 47.1% (4,304/9,139), with
similar proportions in men (47.9%) and women (46.3%)
and an increased risk of infection among pregnant
women. They stated that seropositivity in 0–9 year old
children was 32% (604 of 1,890) with similar prevalence
in males (32.6%) and females (31.9%) [17]. The data in
this report are difficult to interpret because, in most
instances, only percentages of seropositivity are given
without the number of subjects studied; there is a need
for a new updated, population based study.
Data collected with respect to correlates of infection
are also summarized in Table 3.
Handlers in slaughterhouses in Colombia were charac-
terized as an occupational risk group [31,37,39], whereas
this association was not established in Villavicencio
veterinarians [35]. The presence of cats, geographical
differences [17], age, environmental exposure, co-infection
with Ascaris lumbricoides [29], sociocultural characteris-
tics [27], educational level [40], untreated drinking water
and ingestion of meat from wild animals [38] are epi-
demiological factors that have been associated with
human toxoplasmosis in Colombia. Unrelated factors
included physical condition [14], gender, consumption
of undercooked pork [23], socio-demographic condi-
tions [40] and altitude [12].
Various mathematical models of transmission dynamics
of T. gondii in Colombia suggest a synergy between
endemic levels of infection between cats and humans [41].
Consequently, the control of the feral feline population
would have a significant effect on parasite dispersion by
reducing environmental contamination by oocysts [42].
However, controlling the feral cat population does not
interrupt T. gondii propagation [43] because of the prox-
imate relationship between inoculum and infection [44],
which is increased by the dispersion of T. gondii oocysts
in water, which can even reach locales without a definitive
host [45].
Post-natally acquired infections
Little is known of clinical toxoplasmosis in the general
population. Toxoplasmosis associated pneumonia was
reported in a 26 year old [46], and nephritis in a 15 year
old male [47].
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Restrepo [48] mentioned a foodborne outbreak of
toxoplasmosis. Lymphadenopathy and fever were ob-
served in 11 of the 30 persons who participated in a
barbecue where pork was the main food offered in 2005
in Jericó, Antioquia. Affected people became sick 10 to
15 days after the party and they were stated to have
IgM T. gondii antibodies, but no other details were
given. Thus, critical evidence concerning diagnosis is
missing and it is unfortunate that these findings were
mentioned in passing.
A waterborne outbreak of toxoplasmosis was reported
in 18 individuals, 24 to 33 year old male Colombian
soldiers deployed in a remote area in La Macarena,
Meta. All patients had cervical lymphadenopathy, one
had myocarditis, one had pneumonia, and one had
diarrhea. All patients had high (>1024) IgM and IgG
T. gondii antibodies. They were hospitalized, treated with
pyrimethamine, sulfadoxine, and clindamycin, and all re-
covered. Drinking water contaminated with oocysts was
thought to be the source of infection [49].
A well planned epidemiological investigation revealed
that 80% of 501 Colombian soldiers operating in a jungle
were seropositive to T. gondii and four (0.8%) had chorio-
retinal lesions compared with 45% seropostivity in 501
soldiers deployed in urban Bogota, and only one (0.19%)
had chorioretinitis. Drinking water was considered to be
the source of higher seropositivity in jungle deployed
soldiers [38].
Pregnancy and congenital disease
Initial studies concerning acquired toxoplasmosis during
pregnancy reported rates of 1.3% to 8.4% in different re-
gions of Colombia (Table 4). Regardless of geographical
region, the proportions were similar in studies based on
double increase of IgG levels (by ELISA or IFAT technique)
or with specific detection of IgM and IgA antibodies
(Tables 2 and 4).
The national multicentric study revealed that the inci-
dence of congenital toxoplasmosis was not homogenous,
with significant variations between regions as well as a
Table 1 Technical features of serological tests used for detection of T. gondii antibodies in humans and animals in
Colombia
Test, abbreviation Antigens Manufacturer Tables referred
Sabin Feldman dye test, SF Live tachyzoites In-house 2, 3
Skin test Soluble In-house 2, 4
Indirect haemagglutination, IHAT Soluble Not stated 5
Indirect haemagglutination, IHAT Soluble Behringwerke, Germany (Note, these
company have merged into CSL Behring)
www.cslbehring.com
5
Indirect haemagglutination, IHAT Soluble Not state 2
Indirect fluorescent antibody, IFAT Inactivated Not stated 2, 3, 5
Indirect fluorescent antibody, IFAT Inactivated Cappel Laboratories, Cochranville PA, USA 5
Indirect fluorescent antibody, IFAT Inactivated CSL Behring, Germany www.cslbehring.com 2, 3
Indirect fluorescent antibody, IFAT Whole formaldehyde- fixed
tachyzoites
National Institute of Health, Santa fé de
Bogotá, Colombia www.ins.gov.co
2, 3, 4, 5
Modified Agglutination, MAT Formalin-treated whole
tachyzoites
Biomérieux, Craponne, France
www.biomerieux.com
5
Immunosorbent Agglutination Assay test,
ISAGA
Whole tachyzoites-killed Biomérieux, Craponne, France
www.biomerieux.com
2
Enzyme linked fluorescent assay, ELFA
VIDAS® EBV IgG, IgM
Soluble, Biomérieux, Craponne, France
www.biomerieux.com
2, 3, 4
Enzyme linked immunosorbent assay, ELISA
1. Micro ELISA Soluble Not stated 2, 4
2. TOXO IgG Detect ELISA Kit Inactivated BioKit, Barcelona, Spain www.biokit.com 2, 4
3. Toxoplasma ELISA IgG, IgM Soluble Vircell S.L., Grenade, Spain www.vircell.com 2, 3, 4
4. Plateia TOXO IgG, IgM Whole tachyzoites Bio-Rad, Marnes-la-Coquette, France
www.bio-rad.com
2, 3, 4
5. Human® Toxo-IgG Soluble Human Biochemica und Diagnostica mbH,
Wiesbaden, Germany www.human.de/de
2
MEIA Microparticle Enzyme Immunoassay,
AxSYM Toxo IgG, IgM
Soluble Abbott Laboratories, Illinois, USA
www.abbott.com
2, 3, 4
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Table 2 Studies of seroprevalence of T. gondii in human populations conducted in Colombia
Year Population studied Area on the map No. tested Test (cut-off) No. positive (%) Reference
Low risk groups
1956 Indigenous Guambianos CAU 297 SF (16) 88(29.63) [11]
1956 Healthy patients D.C, BOL, ATL, CAL, ANT 36 SF (NR) 22(61.11) [14]
1959 Healthy individuals D.C 205 SF (NR) 47(22.93) [14]
Mental patients 111 23(20.72)
Patients with diverse ailments 38 15(39.47)
1968 Blood donors ANT 184 SF (2) 98(53.26) [15]
1969 Patients from Tunja Hospital BOY 171 SF (8) 41(24.00) [16]
Soldiers BOY 254 134(52.76)
1974 Soldiers from several regions 1771 SF (16) 886(50.02) [12]
1976 Pregnant women ANT 120 SF (NR) 10(8.33) [9]
1980 Pregnant women, nationwide survey 414 IFAT (16) 26(63.04) [17]
1992 Pregnant women (National Institute of Health) D.C 1000 IFAT (16) 590(59.00) [18]
1993 Pregnant women QUI 1617 IFAT (16) 1024(63.33) [19]
1996 Pregnant women CAS 51 IFAT(16) 37(72.55) [20]
Women of reproductive age 327 253(77.37)
1997 Pregnant women QUI 937 IFAT (16) 569(60.73) [21]
1998 Pregnant women D.C 637 IFAT (16) 299(46.94) [22]
2003 Individuals without contact with dogs CAL 300 IFAT (64) 132(44.00) [23]
Dog owners 306 99(32.35)
2005 Pregnant women MET 300 ELISA (>10 UI/ml) 158(52.67) [24]
2005 Pregnant women VAC 955 MEIA (NR) (45.76) [25]
2007 University students without ocular lesion QUI 21 ELISA (>10 UI/ml) 13(61.91) [26]
University students with ocular lesion 12 9(75.00)
2008 Group volunteers Not Stated 140 ELISA (>1 UI) 74(52.86) [27]
2009 National Institute of Health of Colombia D:C 243 ELISA (>10 UI/ml) 137(56.38) [28]
2012 Adult and child population NAR 240 ELISA (>9 UI/ml) 108(45.00) [29]
High-risk groups
1981 Patients with clinical toxoplasmosis VCA 44 IHAT (NR) 24(54.55) [30]
1981 Handlers of slaughterhouses ANT 169 IFAT (16) 45(26.63) [31]
2001 HIV-positive patients D.C 16 IFAT (128) (93.75) [32]
2003 Pregnant women with a history of abortion SUC 100 ELFA (>8 UI/ml) 56(56.00) [33]
2005 Patients with uveitis D.C 25 ELISA (>9 UI/ml) 23(92.00) [34]
2006 Veterinarians MET 86 ELISA (>10 UI/ml) 36(44.19) [35]
2007 HIV patients with cerebral toxoplasmosis QUI 21 ELISA (>10 UI/ml) 16(76.19) [36]
2008 Handlers in slaughterhouses D.C, 82 ELFA (>8 UI/ml) 44(53.66) [37]
SAN 73 48(65.75)
ANT 72 45(62.50)
COR 80 67(83.75)
MET 93 83(89.25)
2009 Soldiers operating in jungle D.C 490 ELISA (NR) 394(80.41) [38]
Urban soldiers operating in Bogotá 501 226(4511)
2011 Colombian newborn screening of Toxoplasma QUI 1517 IC-ELISA (OD 8) 31(2.04) [10]
ATL 2901 2(0.07)
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strong association among high mean annual rainfall
(3,840-2,500 mm/year) and frequency of toxoplasmosis
in women during pregnancy (3-6%). In addition, a mean
of congenital infection was estimated for Colombia as
one of 1,000 newborns (15 confirmed cases between
15,000 children studied); hence with a population of
550,000 newborn per year in the nationwide (Table 5), it
is expected about 550 infected newborns per year [10].
Colombian gynecologists currently use molecular
methods to determine the fetal transmission of T. gondii.
DNA of T. gondii was detected in 10.1% of amniotic fluid
by amplification of the B1 gene in positive samples of
mothers with serological criteria for acute toxoplasmo-
sis in Bogotá [55]. PCR on maternal blood samples is
not a confirmatory test of fetal infection; nevertheless,
a PCR-B1 assay described a positivity of 12% in blood
samples of positive pregnant women from Sincelejo
[56]. Moreover, a serologic test (ELISA ELFA) showed
in the same location seroconversion of 2% during ges-
tational control and neonatal mortality [33] and ex-
posed the burden of congenital toxoplasmosis in the
Caribbean region.
As mentioned in the introduction, the severity of con-
genital toxoplasmosis has been recognized in Colombia
since 1949, when the first case was diagnosed and reported
in 1951 [8,30,51-53]. Ophthalmic complications also have
been reported as strabismus and bilateral chorioretinal
scars [57], hydranencephaly [58], vitreous hyper-echogenicity,
severe hydrocephalus [59] and neuro-ophthalmic infec-
tion [60].
Because until now there was no planned T. gondii
screening program to follow pregnant women and in-
fected children, the information on clinical toxoplas-
mosis in children in Colombia is fragmentary. Here,
we attempted to summarize available information in
Table 5. Although these reports were based on sporadic
cases from Colombian referral centers, it is likely that the
apparent clinical severity is associated with geographical
differences. Indeed, the multicenter study [61], with 25 co-
horts of infected mothers from Europe, North America,
and South America, provided unexpected results and
concluded that ocular risk (47%) and intracranial lesions
(53%) among Colombian children far exceeded that of
European children (14% and 9% respectively).
Table 2 Studies of seroprevalence of T. gondii in human populations conducted in Colombia (Continued)
D.C 5398 12(0.22)
SAN 3036 7(0.23)
NSA 1124 0(0.00)
CAQ 510 9(1.76)
LAG 801 0(0.00)
NR: not registered.
Table 3 Correlates of seroprevalence of T. gondii in human population in Colombia
Population studied (location) No. tested No. positive (%) Correlates of infection Reference
Healthy, mentally ill and other pathologies
(Bogotá)
354 85 (24.0) Patients with various disorders, >41 years old [14]
Blood donors (Medellín) 184 98 (53.3) 16–30 years old [15]
Pregnant women (Quindío) 1617 1024 (63.3) Ownership and contact with cats, consumption of
raw meat, 39 – 44 years old
[19]
Pregnant women (Villavicencio) 300 158 (52.5) Contact with stray cats [24]
Pregnant women (Cali) 955 437 (45.8) 30–39 years old, low socioeconomic level [25]
Group volunteers Colombia – Italy 140 122 (50.8) Age [27]
Asymptomatic population (Manizales) 606 231 (38.1) 50–69 years old [23]
Asymptomatic population (Pasto) 240 108 (45.0) Adults, geographical differences, association with
geohelminth infections
[29]
Handlers in slaughterhouses (Medellín) 169 45 (26.6) Pig meat handlers 33–37 years old [31]
Pregnant women with a history of abortion
(Sincelejo)
100 56 (56.0) Cat exposure [33]
Handlers in slaughterhouses 400 287 (71.8) Ingestion of raw meat, exposure to animals, contact with soil [37]
Soldiers in operations in the Amazon rainforest
(Bogotá)
1001 620 (61.9) Geographical differences, untreated water consumption,
consumption of wild meat
[38]
Colombian newborn screening of Toxoplasma 15.333 61 (0.39) Rate of annual rainfall, geographical differences [10]
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There is no depository of T. gondii isolates from Colombia.
One T. gondii isolate (designated CIBMUQ/HDC) from
blood of a congenitally infected child in Quindío, Armenia
has been deposited in the French National Collection [62].
The infected child was born to a 13-year old mother when
she was in the 33 week of gestation. The child had hepato-
splenomegaly and icterus. Viable T. gondii was isolated from
the peripheral blood buffy coat of the child by bioassay in
mice and cell culture. The strain was mouse-virulent and
genotype I (see section on genotyping).
In Colombia, risk factors associated with congenital
infection are contact with cats [24,33], spatial dispersion
of T. gondii by domestic cats [44], eating undercooked
meat or ingesting untreated water [63], living in house-
holds in marginal areas, socio-economic status [25] and
geographic differences and rainfall [10] (Table 3).
Ocular disease
In Cali, the Institute for Deaf and Blind Children lists
toxoplasmic chorioretinitis as the second leading cause
of congenital blindness [64], and it is the third leading
cause according to the ophthalmologic evaluation of in-
fants under 16 years of age (19/127), affecting a higher
proportion of girls between six months and six years of
age (63.2%) [65], and three cases of ocular toxoplasmosis
occur per 100,000 inhabitants in Quindío [66].
Chorioretinal lesions were diagnosed in patients from
rural and urban areas of Bogotá [34], and in 6% (12/200)
of the student population of the University of Quindío
[26]. Posterior uveitis (67.2%), panuveitis (46.6%) and
unilateral (79.0%) lesions were observed in 39.5% (109/
276) in two Colombian referral centers in Quindío and
Bogotá [67]. Active lesions (45.0%) and recurrent retino-
choroiditis (59.3%) are responsible for decreased visual
acuity in 60.5% of cases with remarkable visual dysfunc-
tion in bilateral condition [68].
In recurrent ocular toxoplasmosis, atypical uveitis is the
most common complication [69]. Episodes of recurrence
can occur at approximately 11 year intervals and are asso-
ciated with the presentation of inactive chorioretinal
lesions and antibiotic therapy without accompanying
steroid treatment [70].
Table 4 Incidence of toxoplasmosis on seroconversion or acute markers rates in different Serological studies in
Colombia (1994–2014)
Population studied Location No. tested Incidence (%) Reference
Pregnant women Medellin 120 8.3 [9]
Newborns Bogotá 1320 1.4 [18]
Pregnant women Armenia 896 1.3 [19]
Pregnant women Quindío 933 1.6 [21]
Pregnant women Sincelejo 100 2.0 [33]
Ophthalmic patients Bogotá 25 12.0 [34]
Veterinarians Villavicencio 86 4.6 [35]
Ophthalmic patients Armenia 9 11.1 [26]
Pregnant women Villavicencio 300 11.0 [24]
Pregnant women Cali 995 2.8 [25]
Handlers in slaughterhouses Bogotá 400 2.8 [37]
Bucaramanga
Medellin
Monteria
Villavicencio
Newborns (seven regions of the country) Armenia 15333 0.5-6.2 [10]
Barranquilla
Bogotá
Bucaramanga
Cúcuta
Florencia
Rioacha
Asymptomatic population Tuquerres 240 4.2 [29]
Tumaco
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Figure 1 (See legend on next page.)
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Immunocompromised patients
An estimated 7,000 to 10,000 new cases of toxoplasmosis
in positive HIV patients occur annually in Colombia [71],
with cerebral toxoplasmosis (CT) as the main complica-
tion. Toxoplasma seropositivity was recorded in patients
from Bogotá (15/16 cases) [32] and in 54 cases from
Cúcuta, with a post-diagnosis survival of 50% [72]. In a
study of 821 autopsies in one hospital in Santander from
2004–2007, T. gondii –associated lesions and parasites
were found in 17 (28.3%) of 60 cases of HIV infected per-
sons [73] and a single case report in Huila [74]. Brain tom-
ography, IgG antibody detection, detection of T. gondii
DNA in peripheral blood are considered effective for the
diagnosis of CT [36,75].
CT shows effects on consciousness, neural disorders
and orientation [36] and complications may occur, includ-
ing chorioretinitis with opacity of the optic nerve [76],
and infection of the spinal cord with involvement of lower
limb motor function; T. gondii tachyzoites were identified
immunohistochemically in biopsy of the thoracic spinal
cord [77].
Toxoplasmosis in animals
Clinical
Four months after a flock of Blackface sheep imported
from Great Britain disembarked in Colombia, premature
births and abortions occurred within the first 48 hours
after birth; bioassays in mice and the histopathological
analysis of fetal and placental products identified T.
gondii, and 44 females tested positive by indirect
hemagglutination tests [78]. It was speculated that ewes
might have become infected with T. gondii during pro-
longed quarantine, and stress of transportation in Great
Britain during transit to Colombia might have caused
abortion.
As part of rabies surveillance, brains of animals sus-
pected to have rabies from 1967–1972 were examined for
Negri bodies and by mouse inoculation: T. gondii was
found in 2 of 235 cats, 8 of 772 dogs, 3 of 93 rats and 1 of
1 guinea pig [79]. The clinical significance of these find-
ings is uncertain.
We are not aware of any other reports of clinical toxo-
plasmosis in Colombia.
Serological and parasitological prevalence
Data are summarized in Tables 6, 7 and Figure 1.
Cats
Seroprevalence in cats deserves special attention because
of the epidemiological importance as definite host of
T. gondii. Jewell et al. [15] surveyed people and pet
cats from Medellin; 112 (62%) of 181 cats had dye test
antibodies with titers of 8 in 16, 32 in 34, 128 in 38,
and 512 in 24 cats. Montoya et al. [88] reported IFAT
antibodies in 25 of 28 cats from the city of Armenia,
but little else was said of the cats surveyed nor of the
IFAT titer. Dubey et al. [82] reported T. gondii anti-
bodies in 52 (30.5%) of 170 cats with titers of 1:20 in 10,
1:40 in 7, 1:80 in 4, 1:160 in 8, 1:320 in 6, and 1:640 in 17.
Thus, most of the cats had high titers; 21 (84%) of 25
cats from Armenia were seropositive compared with 31
(21.3%) from Bogota. Viable T. gondii was isolated from
tissues of 15 of 42 cats with MAT titers of 1:40, but not
from any of the 90 cats with titers of 1:20 or lower.
As of yet, viable T. gondii oocysts have not been dem-
onstrated in cat feces in Colombia. Oocysts were not
found by microscopic examination or by bioassay of
feces of the 170 cats from Armenia and Bogota [82].
Montoya et al. [88] found T. gondii-like oocysts in 18 of
28 cats from Armenia, but there is no evidence to judge
the validity of the findings. Herrera et al. [89] said that
they isolated T. gondii from the feces of a cat but there
is no other information about the cat and method of iso-
lation. With respect to the demonstration of T. gondii
oocysts, bioassay is essential because there are other
T. gondii-like parasites in cat feces [13].
Food animals as sources of infection
Poultry, beef, pork and mutton are the most important
sources of meat consumed by humans in Colombia.
Only limited information is available concerning the
prevalence of T. gondii in food animals (Table 6). Two
surveys that were performed more than 30 years ago
indicated a high prevalence of antibodies in cattle in
Medellin (Table 6). A relatively recent study reported
140 (35.3%) of 397 cattle from Manizales were sero-
positive using a cut-off of 1:32 in the IFAT [83]. Cattle
are considered a poor host for T. gondii and it is ex-
tremely rare to isolate viable T. gondii from beef [13].
Moreover, several serological tests, including the IFAT
and IHAT used give a false positive unless the cut-off
is high [13]. Thus, the role of beef in the epidemiology
of T. gondii is uncertain.
(See figure on previous page.)
Figure 1 Serological studies of T. gondii infection in humans and animals in Colombia (1944–2014). On the map are indicated the natural
regions and states of Colombia. I Caribbean Region: Archipelago of San Andrés and Providencia (SAP), La Guajira (LAG), Atlántico (ATL), Magdalena
(MAG), Cesar (CES), Sucre (SUC), Bolívar (BOL), Córdoba (COR); II Pacific Region: Chocó (CHO), Valle (VAC), Cauca (CAU), Nariño (NAR); III Andean
Region: Bogotá D.C (D.C), Norte de Santander (NSA), Antioquia (ANT), Santander (SAN), Risaralda (RIS), Caldas (CAL), Cundinamarca (CUN), Boyacá
(BOY), Quindío (QUI), Tolima (TOL), Huila (HUI); IV Orinoquía Region: Arauca (ARA), Casanare (CAS), Vichada (VID), Meta (MET) and V Amazon Region:
Putumayo (PUT), Caquetá (CAQ), Guaviare (GUV), Guainía (GUA), Vaupés (VAU), Amazonas (AMA).
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Table 5 Clinical toxoplasmosis in congenitally-infected children in Colombia
Reference Location Type of sample No. tested Infected (%) Sex
(%)
Deaths (%) Neurological
symptoms and
signs (%)
Ocular symptoms
and signs (%)
Hepato-
splenomegaly
(%)
Prematurity
(%)
1981 [30] Cali Referred cases
(1955–1975),
confirmed by
necropsy (21 cases)
or with serological
studies
44 NA Male 25
(56.8)
21 (47.7) Microcephaly and
cerebral calcifications:
30 (68.1)
25 (56.8) 27 (62.5) 8/16 (50.0)
1983 [50] Medellin Referred cases
confirmed by
IFAT test
27 NA Male 17
(63.0)
NR Microcephaly: 20
(74.0) Neurological
psicomotor deficit:
22 (81.5)
Electroencephalogram
changes: 8/14 (57.0)
Strabismus: 9
(33.0) Cataract:
1 (3.7)
Chorioretinitis
11(40.7)
8 (29.0) 5 (18.5)
1997 [21] Quindío Children prenatal
screening
15 1/15 (6.7) Female NR NR Chorioretinitis
(6.7)
NR NR
2000 [51] Bogota Armenia Referred cases
confirmed by IFAT
and ISAGA test
27 NA NR 1 (3.7) Calcification,
hydrocephaly or
microcephaly:
12 (44.4)
Chorioretinitis
11 (40.7)
16 (59.0) 5 (18.5)
2005 [52] Armenia Children prenatal
or newborn
screening
26 (17 by
screening and
11 symptomatic)
NA NR 2 screened
<6 mo. of age
(11.7%) 1 of 11
symptomatic (9%).
17 screened 4 of 11
symptomatic (36%)
13 screened 4
symptomatic
(30%)
26 screened 7
symptomatic
(26.9%)
NR
2006 [53] Quindío Newborn
screening in
referral hospital
200 1/200 (0.5) Female 1 (Respiratory
distress syndrome)
NR NR NR NR
2007 [54] Quindío Newborn
screening in
community
hospitals
322 2/322 (0.5) NR NR NR NR NR NR
2011 [10] Armenia Barranquilla
Riohacha Cucuta
Bogota Bucaramanga
Florencia
National
multicentric
newborn
screening
15,333 218 (1.4) by criteria
for confirmation
assays (109; 50% by
confirmatory assays;
15 (13.7%) by
congenital infection
and 3/15 newborns
with prenatal
treatment
NR 3/15 (20.0) 4/15 (26.6) calcifications;
1/15 (6.6) hydrocephaly
3/15 (20.0)
chorioretinitis
1/15 (6.6)
splenomegaly
1/15 (6.6)
NA: not applicable; NR: not registered.
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A high prevalence (57.9%) of antibodies was recorded
in sheep in six regions of the country (Table 6), but this
study was done more than 35 years ago [86]. T. gondii
infections in pigs had been recorded in 1979 and 1981
but these are also old studies [90,91]. More recently,
T. gondii antibodies were found in 15.3% of 797 >
8 months old pigs from Caldas [83]. The same study
reported T. gondii antibodies in 15.6% of 955 chickens.
There is no information with respect to T. gondii in-
fection in goats used for meat.
Currently, there is a great public interest in food safety
and the presence of viable T. gondii in meat. Serological
surveys from slaughtered animals and the detection of
parasite DNA in meat do not provide a true assessment
of risk to humans because conditions for storage and
treatment of meat from the time of slaughter and con-
sumption affect the viability of parasites. Therefore, studies
are needed to detect the presence of viable T. gondii in
meat from retail meat markets. Lora et al. [92] found T.
gondii DNA by PCR in 95 (52.7%) of 180 (60 samples each)
meat samples (42 pork, 29 beef, 24 chicken meat). This is
an alarming rate of contamination of meat samples from
retail stores and needs confirmation.
Contamination of the environment with T. gondii
There are no specific data on the contamination of
the soil and the environment with T. gondii oocysts in
Colombia. However, the high seroprevalence of T.
gondii in cats suggests that the environment is likely
to be contaminated, because cats that are seropositive
have shed oocysts [13]. Although T. gondii oocysts are
shed for only 1–2 weeks in the life of the cat, millions
of oocysts can be shed and they can survive outdoors
for months.
Seroprevalence of T. gondii in free range chickens
(small farms) is more indicative of soil contamination,
Table 6 Seroprevalence studies of T. gondii in domestic animals in Colombia
Year Area on the map Species Number Serologic test (cut-off) No. positive (%) Reference
1965 D.C Dogs 1000 SF (8) 157 (15.7) [80]
2003 CAL 306 IFAT (32) 124(40.5) [23]
2007 D.C 309 MAT (20) 52(16.8) [81]
1970 ANT Cats 181 SF(8) 112(61.9) [15]
2006 QUI D.C 25137 MAT (20) 21(84.0) 31(21.3) [82]
2006 CAL Horses 777 IFAT (32) 164(21.1) [83]
1981 ANT Pigs 368 HIA (64) 111(30.2) [84]
2006 CAL 797 IFAT (32) 122(15.3) [83]
1981 ANT Cattle 371 HIA (64) 90(24.3) [84]
1981 ANT 361 IFAT (16) 108(29.9) [31]
2006 CAL 397 IFAT (32) 140(35.3) [83]
2005 QUI Backyard chickens 77 MAT (20) 25(32.4) [85]
2006 CAL 955 IFAT (64) 149(15.6) [83]
1978 BOY Sheep 1141 IHAT (16) 724(63.5) [86]
CES 46 30(65.2)
LAG 145 86(59.3)
HUI 96 34(35.4)
NAR 130 59(45.4)
NSA 97 25(25.8)
Table 7 Isolation of viable T. gondii from tissues of animals in Colombia
Host Region Type No. bioassayed Tissues bioassayed No. positive Mouse virulencea T. gondii isolate
designation
Reference
Chicken Quindío Free range 72 Heart, brain 23 16 TgCkCo1-23 [85,87]
Cat Armenia Bogotá Unwanted 116 Heart, brain 15 9 TgCtCo1-15 [82,87]
Dog Bogotá Unwanted 37 Heart, brain, tongue 20 4 TgDgCo1-20 [81]
a100% mortality in outbred mice.
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because chickens feed from the ground, than as a food
source for the main population. Seroprevalence in 77
free range chickens from 9 farms was 32.4%, using a
MAT titer of 20, and viable T. gondii was isolated from
15 of the seropositive chickens [85]. Seropositive chick-
ens were found on all properties, indicating widespread
soil contamination in rural Quindío, Colombia.
The high seroprevalence of T. gondii in herbivores
(Table 6) also indicates that the rural environment is also
contaminated with oocysts. For example, the ingestion
of oocysts is the main mode of transmission of T. gondii
in sheep.
Dogs have been used as sentinel animals for estimat-
ing T. gondii infection in the environment because of
their close contact with humans. Actually, dogs were
found to be risk factor for T. gondii infection in people
in Panama [93]. Dogs are known to eat cat feces and
roll over in cat feces. Thus, their fur becomes contami-
nated with oocysts and children can become infected
by petting infected dogs. In dogs, the prevalence for
T. gondii was recorded in Bogota and Manizales; gen-
der, age, race and type of feeding showed no significant
correlation [23,81,91].
Recently, attention has been drawn to the preva-
lence of T. gondii in bats and epidemics of bat mor-
tality. Most bat species are insectivores and live in
caves. Thus, infection in these bats indicates contam-
ination of caves by oocysts. In this respect, two of 38
Artibeus lituratus bats captured in Tibú, Santander
had dye test antibodies [16].
Genetic characterization of T. gondii strains from
Colombia
Information on genetic typing is summarized here. The
quality of DNA is important for genetic typing and
complete data can be obtained only from DNA extracted
from large numbers of viable parasites, usually cell or
mouse-cultured organisms. More limited information can
be obtained on DNA extracted directly from tissues of
asymptomatic animals. Humans become infected with
T. gondii mostly by consumption of uncooked meat or
the oocysts. Therefore, information on genotypes of iso-
lates from animals, especially cats, is relevant to human
infections.
Different methods have been used to type the isolates.
Earlier information was obtained using serotyping [94]
and polymerase chain reaction-restriction fragment
length polymorphism (PCR-RFLP) with only SAG2
marker [85,95]. Gallego et al. [95] detected T. gondii
DNA in 50 of 146 samples from humans and animals
but did not identify the samples of each species tested.
Of the 50 PCR-positive samples, they characterized 33
samples using the SAG2 gene; 14 human samples (6 con-
genital infection, 3 HIV patients, 1 ocular toxoplasmosis, 3
pregnant women, 1 case of myositis), 2 Myarchus cepha-
lotes, 15 cats (8 brains, 6 hearts, 1 fecal sample), 1
Didelphis marsupialis, and 1 guinea pig. It is really
unfortunate that details of hosts and samples were
not stated. By using the SAG2 gene, 31 of 33 samples
were genotype SAG2 type I. Now we know that SAG2
typing in strains from South America is insufficient
because of the polymorphic nature of the strains in
this region need multilocus analysis. One of these
strains (CIBMUQ/HDC) from the congenitally in-
fected child was subsequently typed using six micro-
satellite markers (TUB2, TgM-A, W35487, BM189462,
BM175053, N82375) and it was found to be type I; it
is mouse virulent [62].
We have recently genotyped 53 isolates of T. gondii
from cats, dogs, and chickens from Colombia using 11
RFLP markers (Tables 7, 8). Nineteen genotypes were
obtained, out of which only two were clonal and both of
these were type I (Table 7). Type I strains are extremely
rare worldwide. Thus, finding three Type I strains out of
54 isolates from Colombia suggests the need for further
study.
Before the discovery of the methods to genotype, T.
gondii strains were grouped as virulent or avirulent for
mice. Howe and Sibley [96] proposed that T. gondii
Table 8 Genotypes of T. gondii from cats, dogs, chickens
from Colombia based on 11 RFLP markers [87]
Toxo DB typea No. of isolates Designation
9, (Chinese1) 1 TgDgCo4
10 (Type I) 2 TgCtCo 2, 7
14 6 TgDgCo9,12,15,18; TgCkCo2;TgCtco14
18 3 TgCtCo 12, 13; TgDgCo3
23 1 TgDgCo19
28 2 TgCtCo 1; TgCkCo5
29 5 TgDgCo1,2,10,20; TgCkCo20
38 13 TgCkCo6,8,10,12,13,15,21,23,24; TgCtCo
4,10,11; TgDgCo17
40 1 TgCtCo5x
44 3 TgDgCo5,6,11
46 3 TgDgCo8,14,16
61 2 TgCtCo 5,6
62 2 TgCtCo3,9
79 1 TgDgCo13
101 1 TgCtCo15
122 1 TgDgCo7
128 1 TgCtCo8
178 1 TgCkCo4
179 2 TgCkCo17,22
188 1 TgCkCo9
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isolates can be grouped in to three types (I, II, III) based
on RFLP typing, and that most strains were clonal. Add-
itionally, Type I strains were 100% lethal for mice, whereas
Types II and III were less pathogenic. Recent studies have
shown that T. gondii isolates are genetically diverse, par-
ticularly those from Brazil and Colombia [4]. Now more
than 200 genotypes of T. gondii are known; most of these
are from South America, and there is an International
Toxoplasma data base (www.toxodb.org) to record the
different genotypes. Here, we have used the ToxoDB to
record genotypes from Colombia (Table 8).
Additionally, T. gondii isolates from Colombia and
Brazil were phenotypically different; 80% of T. gondii
strains from Colombia were 100% lethal to outbred mice
(Table 7), but only two were not Type I.
Currently, there is great scientific interest in finding the
molecular basis of pathogenicity of T. gondii isolates. Now
several genes, including ROP18, are found associated
with virulence, but mouse virulence may not apply to
all hosts [97].
As stated earlier, most of the T. gondii virulence studies
have focused on infections in mice. Recently, scientists in
Colombia have attempted to correlate severity of clinical
toxoplasmosis in patients with genetic make of the strain
and host responses (cytokine production), and found that
the virulent allele of T. gondii ROP18 in ocular toxoplas-
mosis was correlated with severe ocular inflammatory
response [98]. This study additionally found that the
cytokine profile in Colombian patients with ocular
toxoplasmosis was deviated to a Th2 profile [99]; instead,
French patients had a Th1 preferential response [100].
Altogether, these results indicate that some Colombian
strains cause more severe ocular toxoplasmosis due to an
inhibition of the protective effect of IFN-γ. These findings
afford new research avenues to revert the Th2 deviated
immune response in patients with severe forms of ocular
toxoplasmosis.
Conclusions and perspective
From the information summarized here, it is evident
that the toxoplasmosis is a major public health problem
and more than half of the women of child bearing age
are seronegative for T. gondii and at risk of exposure to
Toxoplasma during pregnancy and congenital transmis-
sion to their fetuses. Additionally, the clinical disease in
congenitally infected children is more severe in Colombia
than in Europe. It is tempting to speculate that severity of
toxoplasmosis in children is, in part, related to unusual
genetic types of T. gondii circulating in Brazil and
Colombia. However, only one strain of T. gondii from
a congenitally infected child from Colombia has been
genotyped. Although most studies on toxoplasmosis in
Colombia are limited to one region, studies during
prenatal and newborn programs with adequate follow
up of children are needed in order to ascertain the ex-
tent of clinical damage to children and to correlate with
strain genetic typing. Evaluation of the current official,
evidence-based guidelines will be needed to evaluate the
impact on reducing the burden and sequelae of congenital
infection. Little is known of sources of infection with T.
gondii in humans and animals in Colombia. The level of
contamination of the environment by oocysts and the per-
centage of food animals infected with viable T. gondii is
also unknown. Colombia has vast rural areas and diverse
wildlife. Virtually, nothing is known of the role of wildlife
in the circulation of T. gondii.
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